[1] GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222. [2] 齐元涛,柳言,杜金,等.基于健康生态学模型的我国老年人慢性病共病影响因素研究[J].中国全科医学,2023,26(1):50-57. [3] 解垩. 中国居民慢性病的经济影响[J].世界经济文汇,2011(3):74-86. [4] ZAFAR S Y,PEPPERCORN J M,SCHRAG D,et al.The financial toxicity of cancer treatment:a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience[J].The Oncologist,2013, 18(4):381-390. [5] CARRERA P M,KANTARJIAN H M,BLINDER V S.The financial burden and distress of patients with cancer:Understanding and stepping-up action on the financial toxicity of cancer treatment[J].CA Cancer J Clin,2018,68(2):153-165. [6] De SOUZA J A,YAP B J,WROBLEWSKI K,et al.Measuring financial toxicity as a clinically relevant patient-reported outcome:The validation of the COmprehensive Score for financial Toxicity(COST)[J].Cancer,2017, 123(3):476-484. [7] 于慧会,毕雪,刘运泳.中文版癌症患者报告结局的经济毒性量表信度和效度研究[J].中华流行病学杂志,2017,38(8):1118-1120. [8] CHAN D N S,CHOI K C,NG M S N,et al.Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy(Version 2)[J].Health Qual Life Outcomes,2021,19(1):17. [9] 戈映雪,刘慧妮,江鑫,等.乳腺癌患者经济毒性体验的纵向质性研究[J].心理月刊,2023,18(10):13-16. [10] PATEL M R,ZHANG G,HEISLER M,et al.Measurement and Validation of the Comprehensive Score for Financial Toxicity(COST) in a Population With Diabetes[J].Diabetes Care,2022,45(11):2535-2543. [11] DING R,MORVIL G,GOH B B G,et al.Perception of disease,well-being and financial burden by patients with chronic hepatitis B:A self-reported assessment[J].Ann Acad Med Singap,2022,51(6):378-380. [12] 王咪,林征,周美景,等.炎症性肠病患者经济毒性的研究进展[J].中华现代护理杂志,2022,28(12):1667-1671. [13] HUENIKEN K,DOUGLAS C M,JETHWA A R,et al.Measuring financial toxicity incurred after treatment of head and neck cancer:Development and validation of the Financial Index of Toxicity questionnaire[J].Cancer,2020,126(17):4042-4050. [14] KHERA N.Reporting and grading financial toxicity[J].J Clin Oncol,2014,32(29):3337-3338. [15] WITTE J,MEHLIS K,SURMANN B,et al.Methods for measuring financial toxicity after cancer diagnosis and treatment:A systematic review and its implications[J].Ann Oncol,2019,30(7):1061-1070. [16] GIVEN B A,GIVEN C W,STOMMEL M.Family and out-of-pocket costs for women with breast cancer[J].Cancer Practice,1994,2(3):187-193. [17] 姜华,吕俭霞,牟文轩,等.头颈部肿瘤病人经济毒性指数问卷的汉化及信效度检验[J].护理研究,2023,37(10):1734-1737. [18] 姜男,白锦兵,魏思琪,等.癌症患者经济毒性的影响因素及管理策略研究进展[J].解放军护理杂志,2020,37(9):62-64. [19] DEAN L T,MOSS S L,ROLLINSON S I,et al.Patient recommendations for reducing long-lasting economic burden after breast cancer[J].Cancer,2019,125(11):1929-1940. [20] ESSELEN K M,GOMPERS A,HACKER M R,et al.Evaluating meaningful levels of financial toxicity in gynecologic cancers[J].Int J Gynecol Cancer,2021,31(6):801-806. [21] SCHOLES-ROBERTSON N,BLAZEK K,TONG A,et al.Financial toxicity experienced by rural Australian families with chronic kidney disease[J].Nephrology(Carlton,Vic.),2023,28(8):456-466. [22] VALERO-ELIZONDO J,CHOUAIRI F,KHERA R,et al.Atherosclerotic Cardiovascular Disease,Cancer,and Financial Toxicity Among Adults in the United States[J].JACC Cardio Oncology,2021,3(2):236-246. [23] ILONZE O,FREE K,BREATHETT K.Unequitable Heart Failure Therapy for Black,Hispanic and American-Indian Patients[J].Card Fail Rev,2022,8:e25. [24] BLOOMFELD R S,BICKSTON S J.Financial toxicity in people with inflammatory bowel disease[J].Inflamm Bowel Dis,2021,27(7):1170-1171. [25] WANG S Y,VALERO-ELIZONDO J,ALI H-J,et al.Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the united states[J].J Am Heart Assoc,2021,10(14):e022164. [26] 明玥,王乾沙,黄蓉蓉,等.慢性伤口病人经济毒性研究进展[J].循证护理,2024,10(1):71-74. [27] 赵凌,陈希伟,庞兆烽,等.维持性血液透析患者经济毒性现状及影响因素的研究[J].临床护理杂志,2023,22(1):6-10. [28] 张译友,田媛,帕孜来提·赛登,等.脑卒中患者经济毒性现状及影响因素分析[J].中国临床护理,2023,15(3):183-186. [29] 孙艳玲,况艺,袁潇逸,等.癌症生存者经济毒性现状及影响因素[J].护理学杂志,2022,37(15):24-27,31. [30] 杨义,褚万立,冯光,等.2 997例皮肤软组织损伤住院患者的回顾性分析[J].中华烧伤杂志,2020,36(9):821-829. [31] CARRERA P M,KANTARJIAN H M,BLINDER V S.The financial burden and distress of patients with cancer:Understanding and stepping-up action on the financial toxicity of cancer treatment[J].CA Cancer J Clin,2018,68(2):153-165. [32] UBEL P A,ABERNETHY A P,ZAFAR S Y.Full disclosure--out-of-pocket costs as side effects[J].N Engl J Med,2013,369(16):1484-1486. [33] ZAFAR S Y,ABERNETHY A P.Financial toxicity,Part I:A new name for a growing problem[J].Oncology(Williston Park),2013,27(2):80-81,149. [34] GUNN A H,WARRAICH H J,MENTZ R J.Costs of care and financial hardship among patients with heart failure[J].Am Heart J,2023,269:94-107. [35] HEIDENREICH P A,FONAROW G C,OPSHA Y,et al.Economic issues in heart failure in the united states[J].J Card Fail,2022,28(3):453-466. [36] ABRAMS H R,DURBIN S,HUANG C X,et al.Financial toxicity in cancer care:Origins,impact,and solutions[J].Transl Behav Med,2021, 11(11):2043-2054. [37] LAUZIER S,LÉVESQUE P,MONDOR M,et al.Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses[J].J Natl Cancer Inst,2013,105(4):280-292. [38] 肖德明,林婵兰,张树英,等.慢性心力衰竭患者经济负担调查及规范化治疗对经济负担的影响[J].中国基层医药,2009,16(1):127-128. [39] YABROFF K R,DOWLING E C,GUY G P,et al.Financial hardship associated with cancer in the united states:Findings from a population-based sample of adult cancer survivors[J].J Clin Oncol,2016, 34(3):259-267. [40] PDQ Adult Treatment Editorial Board.Financial Toxicity and Cancer Treatment(PDQ<inline-graphic xlink:href="-40-23-3302/img_1.jpg"/>):Health Professional Version[A].PDQ Cancer Information Summaries[M].Bethesda(MD):National Cancer Institute(US),2002. [41] ZAWUDIE A B,DAKA D W,TESHOME D,et al.Economic burden of diabetic mellitus among patients on follow-up care in hospitals of southwest shewa zone,central ethiopia[J].BMC health Serv Res,2022, 22(1):1398. [42] STEWART S,HOROWITZ J D.Specialist nurse management programmes:Economic benefits in the management of heart failure[J].Pharmacoeconomics,2003,21(4):225-240. [43] 赵钦风,李佳婧,焦晨,等.慢性病患者家庭发生灾难性卫生支出研究[J].卫生经济研究,2021,38(2):7-10. [44] 王龙安,李鑫,李长乐,等.基本医疗保险制度对改善家庭灾难性卫生支出的效果研究[J].经济师,2020(4):58-59. [45] SUKUMAR S,WASFY J H,JANUZZI J L,et al.Financial toxicity of medical management of heart failure:Jacc review topic of the week[J].J Am Coll Cardiol,2023,81(20):2043-2055. [46] SMITH G L,BANEGAS M P,ACQUATI C,et al.Navigating financial toxicity in patients with cancer:A Multidisciplinary management approach[J].CA Cancer J Clin,2022,72(5):437-453. [47] HAMEL L M,DOUGHERTY D W,KIM S,et al.DISCO App:Study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient population[J].Trials,2021,22(1):636. [48] WHEELER S B,BIDDELL C B,MANNING M L,et al.Lessening the Impact of Financial Toxicity(LIFT):A protocol for a multi-site,single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings[J].Trials,2022,23(1):839. [49] 王正君,司峰,周郁秋,等.财务导航模式在癌症患者中的应用进展[J].军事护理,2023,40(12):81-84. [50] CHUBAK J,HAWKES R,DUDZIK C,et al.Pilot Study of Therapy Dog Visits for Inpatient Youth With Cancer[J].J Pediatr Oncol Nurs,2017,34(5):331-341. [51] MADORE S,KILBOURN K,VALVERDE P,et al.Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients[J].Support Care Cancer,2014,22(8):2085-2093. [52] KIRCHER S M,YARBER J,RUTSOHN J,et al.Piloting a financial counseling intervention for patients with cancer receiving chemotherapy[J].J Oncol Pract,2019,15(3):e202-e210. [53] RAO B R,DICKERT N W,MORRIS A A,et al.Heart failure and shared decision-making:Patients open to medication-related cost discussions[J].Circ Heart Fail,2020,13(11):e007094. [54] PIAMJARIYAKUL U,SMITH C E,WERKOWITCH M,et al.Designing and testing an end-of-life discussion intervention for african american patients with heart failure and their families[J].J Hosp Palliat Nurs,2016,18(6):528. [55] THOMSON M C,ALLEN L A,HALPERN S D,et al.Framing benefits in decision aids:Effects of varying contextualizing statements on decisions about sacubitril-valsartan for heart failure[J].MDM Policy Pract, 2021,6(2):23814683211041623. [56] WARRAICH H J,ALI H J R,NASIR K.Financial toxicity with cardiovascular disease management:A balancing act for patients[J].Circ Cardiovasc Qual Outcomes,2020,13(12):e007449. [57] DICKERT N W,MITCHELL A R,VENECHUK G E,et al.Show me the money:Patients' perspectives on a decision aid for sacubitril/valsartan addressing out-of-pocket cost[J].Circ Cardiovasc Qual Outcomes, 2020, 13(12):e007070. [58] THAKER D A,MONYPENNY R,OLVER I,et al.Cost savings from a telemedicine model of care in northern Queensland,Australia[J].Med J Aust,2013,199(6):414-417. [59] BIDDELL C B,KASOW K A,KILLELA M K,et al.Understanding the financial and psychological impact of employment disruption among caregivers of pediatric HSCT recipients:A mixed methods analysis[J].Support Care Cancer,2022,30(6):4747-4757. [60] LONGACRE M L,WEBER-RALEY L,KENT E E.Cancer caregiving while employed:Caregiving roles,employment adjustments,employer assistance,and preferences for support[J].J Cancer Educ,2021,36(5):920-932. |